ELV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit – captioned Miller v. Elevance... Read more.
IMVARIA Reports Multi-Site Clinical Experience With FDA-Authorized AI Diagnostic Service for Idiopathic Pulmonary Fibrosis at ATS 2025
Presenting real-world use of Fibresolve, the first-of-its-kind AI-powered adjunctive diagnostic service supporting assessment of suspected Interstitial Lung Disease... Read more.
Capital One Completes Acquisition of Discover
MCLEAN, Va.–(BUSINESS WIRE)–Capital One Financial Corporation (NYSE: COF) today announced that it has completed its acquisition of Discover Financial... Read more.
Tornado Recovery: U-Haul Offers 30 Days Free Storage in 3 States
Friday’s storms have created a need for disaster relief across parts of the Midwest ST. LOUIS–(BUSINESS WIRE)–U-Haul® has made 24 Company stores across... Read more.
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers... Read more.
Clover Expands Commitment to the Restaurant Industry with the Launch of Clover Hospitality by BentoBox
Live from the 2025 National Restaurant Association Show, the Top-of-the-Line Solution Proves There’s a Clover for Every Restaurant CHICAGO–(BUSINESS WIRE)–Clover,... Read more.
ZYXI Deadline: Rosen Law Firm Urges Zynex, Inc. (NASDAQ: ZYXI) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers... Read more.
Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia
Preclinical research demonstrates that a single administration of BE-102 provides continuous secretion of active alkaline phosphatase (ALP) in vivo out to 6 months... Read more.
AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B
– Analysis Presented at the Heart Failure 2025 Congress Supports Primary Findings, Highlighting Impact of AMVUTTRA, which Delivers Rapid Knockdown of Transthyretin... Read more.
Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launch Contract, Sets Schedule For the Next iQPS Mission
MAHIA, New Zealand–(BUSINESS WIRE)–$RKLB–Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch... Read more.